<- Go Home
Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Market Cap
$49.3M
Volume
102.3K
Cash and Equivalents
$5.5M
EBITDA
-$36.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$33.83
52 Week Low
$5.67
Dividend
N/A
Price / Book Value
0.46
Price / Earnings
-1.63
Price / Tangible Book Value
0.46
Enterprise Value
$66.7M
Enterprise Value / EBITDA
-1.90
Operating Income
-$36.9M
Return on Equity
25.33%
Return on Assets
-10.77
Cash and Short Term Investments
$69.7M
Debt
$87.0M
Equity
$107.4M
Revenue
N/A
Unlevered FCF
$89.4M
Sector
Biotechnology
Category
N/A